Intas’ manufacturing capabilities are aligned to a business strategy of developing and commercializing highest quality products across the glob. Intas’ has extensive capabilities to develop and manufacture Recombinant proteins, monoclonal antibodies, pegylated technology platform products and plasma derived products.
Microbial Fermentation & Mammalian Cell Culture Manufacturing Facilities
The company’s capabilities encompass small-scale to large-scale microbial fermentation, mammalian cell culture, protein & antibody purification, pegylation, lyophilization, aseptic formulation and fill-finish. With complete backward integration, the facility carries-out bulk-drug manufacturing and formulation fill-finish activity for pre-filled syringes, vials and pen-fill for devices. Intas’ International GMP compliant manufacturing facilities are supported by modern process development and quality control infrastructure. These facilities are accredited by the local and international regulatory agencies. The manufacturing facility has garnered European Union - Good Manufacturing Practice (EU-GMP) certification for Drug Substance and Drug Product.
For more information, please write to